Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Jacobson

Showing results (521-530 of 792) with videos related to

Pageof 80
Sort By:
European Journal of Medicinal Chemistry|November 22, 2012
Probes for narcotic receptor mediated phenomena. 46. N-substituted-2,3,4,9,10,10a-hexahydro-1H-1,4a-(epiminoethano)phenanthren-6- and 8-ols - carbocyclic relatives of f-oxide-bridged phenylmorphansFuying Li, Jason A Deck, Christina M Dersch, et al.
European Journal of Pharmacology|January 24, 1989
Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sitesR B Rothman, V Bykov, J B Long, et al.
JCO Precision Oncology|February 9, 2022
Multi-Institutional, Prospective Clinical Utility Study Evaluating the Impact of the 92-Gene Assay (CancerTYPE ID) on Final Diagnosis and Treatment Planning in Patients With Metastatic Cancer With an Unknown or Unclear DiagnosisSachdev P Thomas, Lauren E Jacobson, Anthony R Victorio, et al.
Clinical Breast Cancer|June 12, 2020
Patterns of Failure in Women Who Have Residual Nodal Disease After Neoadjuvant Chemotherapy for Breast Cancer According to Extent of Lymph Node SurgeryMargaret M Kozak, Kathleen C Horst, Paulina M Gutkin, et al.
Women'S Health Issues : Official Publication of the Jacobs Institute of Women'S Health|July 4, 2025
Safety Net Clinic Utilization for Sexual and Reproductive Health Services Among U.S.- and Foreign-Born Mexican-Origin WomenBlair G Darney, Biani Saavedra-Avendaño, Emily R Boniface, et al.
Parkinsonism & Related Disorders|April 13, 2011
Rescue leads: a salvage technique for selected patients with a suboptimal response to standard DBS therapyGenko Oyama, Kelly D Foote, Nelson Hwynn, et al.
Surgical Endoscopy|July 1, 1996
Conversion of laparoscopic to open cholecystectomy. An analysis of risk factorsE A Wiebke, A L Pruitt, T J Howard, et al.
NIDA Research Monograph|January 1, 1984
Evidence for separation of anesthetic activity from prototypic phencyclidine action in drug discrimination by molecular modification of dioxadrol, a phencyclidine-like dissociative anestheticE A Harrison, M F Rafferty, K C Rice, et al.
European Journal of Pharmacology|September 13, 1988
Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanateA N Schoffelmeer, K C Rice, A E Jacobson, et al.
European Journal of Pharmacology|May 13, 1986
Morphine tolerance increases mu-noncompetitive delta binding sitesR B Rothman, J A Danks, A E Jacobson, et al.
Pageof 80

Showing results (521-530 of 792) with videos related to

Sort By:
Pageof 80
European Journal of Medicinal Chemistry|November 22, 2012
Probes for narcotic receptor mediated phenomena. 46. N-substituted-2,3,4,9,10,10a-hexahydro-1H-1,4a-(epiminoethano)phenanthren-6- and 8-ols - carbocyclic relatives of f-oxide-bridged phenylmorphansFuying Li, Jason A Deck, Christina M Dersch, et al.
European Journal of Pharmacology|January 24, 1989
Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sitesR B Rothman, V Bykov, J B Long, et al.
JCO Precision Oncology|February 9, 2022
Multi-Institutional, Prospective Clinical Utility Study Evaluating the Impact of the 92-Gene Assay (CancerTYPE ID) on Final Diagnosis and Treatment Planning in Patients With Metastatic Cancer With an Unknown or Unclear DiagnosisSachdev P Thomas, Lauren E Jacobson, Anthony R Victorio, et al.
Clinical Breast Cancer|June 12, 2020
Patterns of Failure in Women Who Have Residual Nodal Disease After Neoadjuvant Chemotherapy for Breast Cancer According to Extent of Lymph Node SurgeryMargaret M Kozak, Kathleen C Horst, Paulina M Gutkin, et al.
Women'S Health Issues : Official Publication of the Jacobs Institute of Women'S Health|July 4, 2025
Safety Net Clinic Utilization for Sexual and Reproductive Health Services Among U.S.- and Foreign-Born Mexican-Origin WomenBlair G Darney, Biani Saavedra-Avendaño, Emily R Boniface, et al.
Parkinsonism & Related Disorders|April 13, 2011
Rescue leads: a salvage technique for selected patients with a suboptimal response to standard DBS therapyGenko Oyama, Kelly D Foote, Nelson Hwynn, et al.
Surgical Endoscopy|July 1, 1996
Conversion of laparoscopic to open cholecystectomy. An analysis of risk factorsE A Wiebke, A L Pruitt, T J Howard, et al.
NIDA Research Monograph|January 1, 1984
Evidence for separation of anesthetic activity from prototypic phencyclidine action in drug discrimination by molecular modification of dioxadrol, a phencyclidine-like dissociative anestheticE A Harrison, M F Rafferty, K C Rice, et al.
European Journal of Pharmacology|September 13, 1988
Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanateA N Schoffelmeer, K C Rice, A E Jacobson, et al.
European Journal of Pharmacology|May 13, 1986
Morphine tolerance increases mu-noncompetitive delta binding sitesR B Rothman, J A Danks, A E Jacobson, et al.
Pageof 80